R620W functional polymorphism of protein tyrosine phosphatase non-receptor type 22 is not associated with pulmonary tuberculosis in Zahedan, southeast Iran

Genetics and Molecular Research

Volumn 11, Issue 2, 2012, Pages 1075-1081

  Kouhpayeh, H R ^a   Hashemi, M ^b,c   Hashemi, S A ^a   Moazeni Roodi, A ^a   Naderi, M ^a   Sharifi Mood, B ^a   Taheri, M ^b   Mohammadi, M ^d   Ghavami, S ^e  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Polymorphism; PTPN22; Tuberculosis

Indexed keywords

CYSTEINE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; THREONINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84930485479     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.April.27.6     Document Type: Article

References (40)

1. Ban Y, Tozaki T, Taniyama M and Tomita M (2005). The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15: 1115-1118.
2. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, et al. (2004). A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337.
3. Bellamy R, Beyers N, McAdam KP, Ruwende C, et al. (2000). Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc. Natl. Acad. Sci. U. S. A. 97: 8005-8009.
4. Bottini N, Musumeci L, Alonso A, Rahmouni S, et al. (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338.
5. Bravo MJ, Colmenero JD, Queipo-Ortuno MI, Morata P, et al. (2009). PTPN22 C1858T polymorphism and human brucellosis. Scand J. Infect. Dis. 41: 109-112.
6. Cervino AC, Lakiss S, Sow O, Bellamy R, et al. (2002). Fine mapping of a putative tuberculosis-susceptibility locus on chromosome 15q11-13 in African families. Hum. Mol. Genet. 11: 1599-1603.
7. Chabchoub G, Maalej A, Petit-Teixeira E, Glikmans E, et al. (2006). Polymorphisms in the protein tyrosine phosphatase (PTPN22) gene is not associated with autoimmune thyroid in a large affected Tunisian family. Clin. Immunol. 120: 235-236.
8. Chabchoub G, Teixiera EP, Maalej A, Ben HM, et al. (2009). The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann. Hum. Biol. 36: 342-349.
9. Chelala C, Duchatelet S, Joffret ML, Bergholdt R, et al. (2007). PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes 56: 522-526.
10. Cohen S, Dadi H, Shaoul E, Sharfe N, et al. (1999). Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93: 2013-2024.
11. Comstock GW (1978). Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. Dis. 117: 621-624.
12. Douroudis K, Prans E, Haller K, Nemvalts V, et al. (2008). Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 72: 425-430.
13. Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, et al. (2005a). PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun. 6: 628-631.
14. Gomez LM, Anaya JM and Martin J (2005b). Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum. Immunol. 66: 1242-1247.
15. Guide SV and Holland SM (2002). Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect. Dis. Clin. North Am. 16: 163-186.
16. Hashemi M, Moazeni-Roodi AK, Fazaeli A, Sandoughi M, et al. (2010a). Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet. Mol. Res. 9: 333-339.
17. Hashemi M, Moazeni-Roodi AK, Fazaeli A, Sandoughi M, et al. (2010b). The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis. Genet. Mol. Res. 9: 1735-1741.
18. Hashemi M, Hoseini H, Yaghmaei P, Moazeni-Roodi A, et al. (2011a). Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell Biol. 30: 569-575.
19. Hashemi M, Sharifi-Mood B, Nezamdoost M, Moazeni-Roodi A, et al. (2011b). Functional polymorphism of interferon-gamma (IFN-gamma) gene +874T/A polymorphism is associated with pulmonary tuberculosis in Zahedan, Southeast Iran. Prague Med. Rep. 112: 38-43.
20. Hermiston ML, Xu Z, Majeti R and Weiss A (2002). Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J. Clin. Invest. 109: 9-14.
21. Hill RJ, Zozulya S, Lu YL, Ward K, et al. (2002). The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp. Hematol. 30: 237-244.
22. Hinks A, Worthington J and Thomson W (2006). The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology 45: 365-368.
23. Ikegami H, Kawabata Y, Noso S, Fujisawa T, et al. (2007). Genetics of type 1 diabetes in Asian and Caucasian populations. Diabetes Res. Clin. Pract. 77 (Suppl 1): S116-S121.
24. Jagiello P, Aries P, Arning L, Wagenleiter SE, et al. (2005). The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum. 52: 4039-4043.
25. Lamsyah H, Rueda B, Baassi L, Elaouad R, et al. (2009). Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. Tissue Antigens 74: 228-232.
26. Lee YH, Rho YH, Choi SJ, Ji JD, et al. (2007). The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 46: 49-56.
27. Mori M, Yamada R, Kobayashi K, Kawaida R, et al. (2005). Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J. Hum. Genet. 50: 264-266.
28. Mustelin T, Brockdorff J, Rudbeck L, Gjorloff-Wingren A, et al. (1999). The next wave: protein tyrosine phosphatases enter T cell antigen receptor signalling. Cell Signal. 11: 637-650.
29. Mustelin T, Abraham RT, Rudd CE, Alonso A, et al. (2002). Protein tyrosine phosphorylation in T cell signaling. Front Biosci. 7: d918-d969.
30. Naderi M, Hashemi M, Kouhpayeh H and Ahmadi R (2009). The status of serum procalcitonin in pulmonary tuberculosis and nontuberculosis pulmonary disease. J. Pak. Med. Assoc. 59: 647-648.
31. Naderi M, Hashemi M, Mehdizadeh A and Mehrabifar H (2010). Serum adenosine deaminase activity and total antioxidant capacity of plasma in pulmonary tuberculosis and non-tuberculosis pulmonary disease. Turk. J. Med. Sci. 40: 701-706.
32. North RJ and Jung YJ (2004). Immunity to tuberculosis. Annu. Rev. Immunol. 22: 599-623.
33. Orozco G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, et al. (2005). Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 52: 219-224.
34. Porter JD and McAdam KP (1994). The re-emergence of tuberculosis. Annu. Rev. Public Health 15: 303-323.
35. Qu HQ, Fisher-Hoch SP and McCormick JB (2011). Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases. Int. J. Infect. Dis. 15: e305-e313.
36. Reddy MV, Johansson M, Sturfelt G, Jonsen A, et al. (2005). The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun. 6: 658-662.
37. Seldin MF, Shigeta R, Laiho K, Li H, et al. (2005). Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun. 6: 720-722.
38. Veillette A, Latour S and Davidson D (2002). Negative regulation of immunoreceptor signaling. Annu. Rev. Immunol. 20: 669-707.
39. Wipff J, Allanore Y, Kahan A, Meyer O, et al. (2006). Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population. Ann. Rheum. Dis. 65: 1230-1232.
40. Zhang ZH, Chen F, Zhang XL, Jin Y, et al. (2008). PTPN22 allele polymorphisms in 15 Chinese populations. Int. J. Immunogenet. 35: 433-437.